VSee Health, Inc.
VSEE
$1.05
$0.043.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 98.07% | 104.90% | 170.29% | 131.10% | 32.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 98.07% | 104.90% | 170.29% | 131.10% | 32.66% |
| Cost of Revenue | 92.77% | 278.33% | 252.79% | 96.78% | 97.05% |
| Gross Profit | 104.44% | 50.64% | 137.60% | 147.97% | -4.77% |
| SG&A Expenses | 122.16% | 234.27% | 309.31% | 210.79% | 4.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.67% | 245.69% | 296.29% | 179.02% | 28.14% |
| Operating Income | -220.18% | -1,504.37% | -840.50% | -441.20% | -18.33% |
| Income Before Tax | -11.27% | -4,262.34% | -1,328.84% | -15,639.27% | -288.81% |
| Income Tax Expenses | 100.27% | -- | -52.73% | -135.34% | -862.39% |
| Earnings from Continuing Operations | -292.33% | -4,276.58% | -104.85% | -52,386.31% | -55.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 700.00% |
| Net Income | -312.13% | -6,404.78% | -102.37% | -46,522.97% | -49.34% |
| EBIT | -220.18% | -1,504.37% | -840.50% | -441.20% | -18.33% |
| EBITDA | -128.70% | -1,004.05% | -638.00% | -196.53% | -18.12% |
| EPS Basic | -33.03% | -2,527.00% | -28.10% | -30,822.52% | -30.71% |
| Normalized Basic EPS | 61.18% | -2,260.00% | -420.07% | 884.65% | -211.25% |
| EPS Diluted | -33.03% | -2,527.00% | -28.10% | -30,822.52% | -30.71% |
| Normalized Diluted EPS | 61.18% | -2,260.00% | -420.07% | 884.65% | -211.25% |
| Average Basic Shares Outstanding | 209.72% | 159.88% | 58.01% | 50.80% | 14.29% |
| Average Diluted Shares Outstanding | 209.72% | 159.88% | 58.01% | 50.80% | 14.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |